Original article
The Female-Predominant Persistent Immune Dysregulation of the Post-COVID Syndrome

https://doi.org/10.1016/j.mayocp.2021.11.033Get rights and content
Under a Creative Commons license
open access

Abstract

Objective

To describe the clinical data from the first 108 patients seen in the Mayo Clinic post–COVID-19 care clinic (PCOCC).

Methods

After Institutional Review Board approval, we reviewed the charts of the first 108 patients seen between January 19, 2021, and April 29, 2021, in the PCOCC and abstracted from the electronic medical record into a standardized database to facilitate analysis. Patients were grouped into phenotypes by expert review.

Results

Most of the patients seen in our clinic were female (75%; 81/108), and the median age at presentation was 46 years (interquartile range, 37 to 55 years). All had post-acute sequelae of SARS-CoV-2 infection, with 6 clinical phenotypes being identified: fatigue predominant (n=69), dyspnea predominant (n=23), myalgia predominant (n=6), orthostasis predominant (n=6), chest pain predominant (n=3), and headache predominant (n=1). The fatigue-predominant phenotype was more common in women, and the dyspnea-predominant phenotype was more common in men. Interleukin 6 (IL-6) was elevated in 61% of patients (69% of women; P=.0046), which was more common than elevation in C-reactive protein and erythrocyte sedimentation rate, identified in 17% and 20% of cases, respectively.

Conclusion

In our PCOCC, we observed several distinct clinical phenotypes. Fatigue predominance was the most common presentation and was associated with elevated IL-6 levels and female sex. Dyspnea predominance was more common in men and was not associated with elevated IL-6 levels. IL-6 levels were more likely than erythrocyte sedimentation rate and C-reactive protein to be elevated in patients with post-acute sequelae of SARS-CoV-2 infection.

Abbreviations and Acronyms

COVID-19
coronavirus disease 2019
CRP
C-reactive protein
CRS
cytokine release syndrome
CS
central sensitization
ESR
erythrocyte sedimentation rate
IL
interleukin
PASC
post-acute sequelae of SARS-CoV-2 infection
PCOCC
post–COVID-19 care clinic
PoCoS
post-COVID syndrome
POTS
postural orthostatic tachycardia syndrome
SARS-CoV-2
severe acute respiratory syndrome coronavirus 2

Cited by (0)

For editorial comment, see page 429

Grant Support: REDCap software provided by internal grant UL1TR002377.

Potential Competing Interests: A.D.B. is supported by grants from the National Institute of Allergy and Infectious Diseases (AI110173 and AI120698), amfAR (109593), and Mayo Clinic (HH Sheik Khalifa Bib Zayed Al-Nahyan Named Professorship of Infectious Diseases). A.D.B. is a paid consultant for Abbvie and Flambeau Diagnostics; is a paid member of the Data and Safety Monitoring Board for Corvus Pharmaceuticals, Equillium, and Excision Biotherapeutics; has received fees for speaking for Reach MD; owns equity for scientific advisory work in Zentalis and Nference; and is founder and President of Splissen Therapeutics. R.T.H. is a consultant for Nestle.

Data Previously Presented: A preliminary report of this work was previously published on medRxiv, June 2, 2021. https://doi.org/10.1101/2021.05.25.21257820